 Well, for me, schizophrenia is a fascinating disorder. There's very little that you can see in brain scans or other kinds of biological tests to show what's different about the brains of individuals with psychosis from individuals who do not have psychosis. I'm Neil Malhotra from the Zephyr Hillside Hospital in New York and I'm the principal investigator of this project. We're looking to see if a treatment strategy called transcranial magnetic stimulation may have the ability to actually improve cognitive function in individuals with schizophrenia. And what that tends to do is either turn on or turn off brain circuits. What we hope that that leads to, of course, are individuals doing better in their day-to-day life and out and about. TMS is FDA approved for the treatment of depression, obsessive compulsive disorder, and smoking cessation. It has not yet been tried as much in individuals with schizophrenia. So it's very exciting for us to start this study for the first time.